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ABSTRACT: Two novel types of hydrogel microspheres (MS) are pre-
sented.  First, one-component microspheres (1-comMS) were produced 
from sodium alginate (Na-alg) equipped with thiol-functionalized hydrox-
yl groups. The functionalization pathway included the conversion of Na-
alg into tetrabutylammonium alginate, insertion of new carboxyl groups, 
grafting of α-amine-ω-thiol poly(ethylene glycol), and restoration of the 
sodium salt. This modification conserves all original carboxyl groups of 
Na-alg and allows for covalent disulfide bond formation in addition to 
ionic crosslinking. Second, two-component microspheres (2-comMS) 
were obtained from a mixture of Na-alg and Na-alg functionalized with cysteamine. This functionalization was achieved by grafting cystamine 
dihydrochloride on some carboxyl groups followed by the reduction to cysteamine. Using the one-step MS formation process developed for 
both MS types, very fast ionic gelation with calcium ions conserves the spherical shape of the polymer solution droplets upon extrusion into 
the gelation bath, while simultaneously occurring slow covalent crosslinking reinforces the hydrogels. The physical properties of both MS 
types are adjustable by varying the polymer concentration, the degree of grafting, and the mixing ratio. In vitro cell microencapsulation studies 
confirmed the cytocompatibility of 1-comMS and 2-comMS.  
INTRODUCTION  
The water-soluble biopolymer sodium alginate (Na-alg) spontane-
ously forms hydrogels under mild conditions of pH and tempera-
ture upon replacing the sodium ions by divalent cations.1-6 In par-
ticular, the hydrogel calcium alginate (Ca-alg) is considered suita-
ble for a variety of pharmaceutical, biological and medical applica-
tions including cell immobilization.7,8 A special application is the 
entrapment of cells in micro-sized 3D hydrogels. The small dimen-
sion of such microspheres (MS) provides an optimal sur-
face/volume ratio and is favorable for the mass transfer between 
cells and their environment, presupposed that the hydrogel is suffi-
ciently stable and has the desired network density. Immobilization 
of cells in hydrogel MS is the prerequisite for the success of several 
cell therapies that are currently under development or in clinical 
trials. Some examples that highlight the variety of potential applica-
tions are external organ support,9 treatments relying on cell allo- or 
xenotransplantation,10,11 and prosthetic gene networks.12,13 Howev-
er, for alginate-based MS prepared by only ionic crosslinking with 
divalent cations, insufficient mechanical properties, stability and 
permselectivity have been argued.5,14-17 Moreover, due to the lack of 
optimal materials, which meet the general requirements for cell 
microencapsulation and which in addition can be adapted to the 
needs of specific cell types and applications, the development of 
innovative cell therapies is slowly progressing.  
To address these issues, different strategies have focused on either 
the improvement of Ca-alg MS or the replacement of Ca-alg by 
other materials. Despite some progress, coating Ca-alg MS with 
polycations such as poly(L-lysine),18-23 poly(L-ornithine)24,25 or 
poly(methylene guanidine)26-28 or employing other polymers10,29-36 
was frequently accompanied by reduced biocompatibility, and also 
more complicated multi-step MS formation processes were re-
quired.37-40 In another way, promising approaches include the de-
velopment of alginate derivatives with enhanced performance and 
the combination of Na-alg with poly(ethylene glycol) (PEG).41-51 
In accordance with this concept, we have recently developed two 
types of Na-alg-based MS produced by a one-step process, and we 
have shown their suitability for cell microencapsulation.11,52-54 The 
first was a one-component MS (1-comMS) formed from a Na-alg 
derivative with heterobifunctional PEG grafted on the carboxyl 
groups.52 The other was a two-component MS (2-comMS) com-
posed of an interpenetrating polymer network of Ca-alg and cova-
lently crosslinked vinyl sulfone-terminated multi-arm 
poly(ethylene glycol).11, 53,54 
The overall objective of the present study was to further extend the 
material basis for cell microencapsulation, i.e., to synthesize Na-alg 
derivatives, which yield in one-step processes MS with favorable 
and tunable properties. First, we modified hydroxyl groups of Na-
alg to allow the grafting of α-amine-ω-thiol-poly(ethylene glycol), 
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 so maintaining all carboxyl groups for ionic crosslinking. Second, 
another reagent than PEG derivatives, cyteamine, was used for the 
Na-alg functionalization. The resulting Na-alg derivatives and hy-
drogels were characterized in terms of chemical composition, sta-
bility, permeability and mechanical resistance. Finally, the cyto-
compatibility of 1-comMS and 2-comMS, produced either from 
PEG-grafted Na-alg or from cysteamine grafted Na-alg mixed with 
Na-alg, was evaluated by microencapsulation of primary human 
foreskin fibroblasts (EDX cells). 
 
EXPERIMENTAL SECTION  
Materials. Na-alg Kelton HV (lot no. 61650A, [η] = 813 mL g-1 in 
0.1 M NaCl, T = 25 °C, G/M = 0.6) and Na-alg Kelton LV (lot no. 
46198A, [η] = 475 mL g-1 in 0.1 M NaCl, G/M = 0.69) were ob-
tained from Kelco  (San Diego, USA, CA). Na-alg PRONOVA UP 
LVM was from FMC BioPolymer (Novamatrix, Drammen, Nor-
way, batch no FP-506-01, [η] = 405 mL g-1 in 0.1 M NaCl).55,56 α-
amine-ω-thiol-poly(ethylene glycol) (NH2-PEG-SH, 2000 g mol-1) 
was purchased from JenKem (JenKem Technology USA, Allen, 
TX, USA). Tetrabutylammonium hydroxide (TBAOH), N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC), 2-(N-morpholino) ethanesulfonic acid (MES), sodium 
cyanoborohydride (NaCNBH3),  tris(2-carboxylethyl)phosphine 
hydrochloride (TCEP), cystamine dihydrochloride, 3-(N-
morpholino)propanesulfonic acid (MOPS), calcium chloride di-
hydrate (CaCl2∙2H2O), fluorescein isothiocyanate-dextran (FITC-
dextran, 40, 70 and 150 kg mol-1), as well as all other common rea-
gents and solvents were purchased from Sigma (Sigma-Aldrich, 
Switzerland). All reagents were analytical grade and were used 
without further purification. Dialysis bags (Visking type 36/32, 
cellulose, MWCO 14 kg mol-1) were obtained from Carl Roth 
(Karlsruhe, Germany).  
Synthesis Pathway of Na-alg-PEG (Scheme 1). To convert Na-
alg (1) into alginic acid, Kelton HV (4 g) was added to a mixture of 
aqueous HCl (60 mL, 0.6 N) and ethanol (60 mL), and the solu-
tion was stirred overnight at 4 °C. The resulting solid was separated 
by vacuum filtration, washed with ethanol and acetone, and dried 
overnight under vacuum at 40 °C. Dried alginic acid was dispersed 
in water (200 mL), and TBAOH (40% in water) was added drop-
wise until the polymer was fully dissolved. The pH was adjusted 
between 7 and 10, and the solution was dialyzed and finally freeze-
dried to afford TBA-alg (2) as a white solid. Under nitrogen at-
mosphere, DMSO (10 mL) was added to TBA-alg (2) (150 mg, 1 
equiv.) in a flask equipped with condenser, and the suspension was 
stirred at RT until good dispersion. Upon addition of molecular 
sieves, the temperature was raised to 40 °C. The amounts reported 
subsequently refer to reaction conditions no. 13 presented in the 
Supporting Information (SI) (SI 1, Table S1). Succinic anhydride 
(0.7 g, 7.1 mmol, 2 equiv.) and pyridine (0.05 mL, 6.1 mmol, 1.7 
equiv.) were added, and the reaction mixture was stirred for 1 h at 
40 °C. The polymer was precipitated by addition of ethyl acetate, 
filtered, and dried under vacuum. The crude product was dissolved 
in water, dialyzed (3 days), and freeze-dried to afford compound 
(5) as a white solid. Compound (5) (100 mg, 1 equiv.) and MES 
(150 mg) were dissolved in 10 mL of water and stirred at RT until 
good dispersion. NH2-PEG-SH (77.4 mg, 0.2 equiv.) was added, 
followed by EDC (81.6 mg, 2.2 equiv.). The reaction mixture was 
stirred for 2 h at RT. TCEP (0.5 mL, 1 M) and MES (5 mL, 0.12 
mg mL-1) were added to the polymer solution inside the dialysis 
tube prior to the dialysis and then at each water exchange (twice 
daily for 2 days). At day 2, the pH was adjusted between 7 and 8 
and the dialysis continued for one day in the presence of TCEP 
(0.5 mL, 1 M).  After adjustment of the pH and two filtrations (70 
μm and 0.22 μm), the product was freeze-dried to yield Na-alg-
PEG (4) as a white solid. 
Synthesis Pathway of Na-alg-cys (Scheme 2). Na-alg Kelton HV 
(1 g, 5 mmol) and MES (1.2 g, 5.5 mmol) were dissolved in 100 
mL of distilled water and shaken at 4 °C until complete dissolution. 
Cystamine dihydrochloride (2.25 g, 10 mmol) was added. After 
stirring for 10 min at RT, EDC (900, 700, or 500 mg) was added 
and stirring was continued for 2 h at RT. The mixture was dialyzed 
against distilled water for 24 h and freeze-dried. The resulting solid 
was re-dissolved in a solution containing 100 mM TCEP in 10 mM 
MOPS (1 g polymer in 50 mL solution). Purification was achieved 
by 24 h dialysis against distilled water with four times water re-
placement. The purified solution was filtered  (0.22 μm) and lyoph-
ilized yielding Na-alg-cys-500, Na-alg-cys-700, or Na-alg-cys-900 
(5) as white solids. 
Analytical Techniques. 1H-NMR spectra were recorded on a 
Bruker-ARX-400 spectrometer (400 MHz); the chemical shift was 
referred to the solvent peak (δ = 4.79 for deuterium oxide). 13C-
NMR spectra were recorded on a Bruker-DRX-600 spectrometer 
(600 MHz, cryo). FTIR spectra were recorded on a Perkin Elmer 
spectrometer (Spectrum One) equipped with Spectrum software 
(version 5.3, Perkin Elmer). A rolling-ball viscometer (Lovis 2000 
ME, Anton Paar, Graz, Austria) was used to measure both the solu-
tion viscosity and intrinsic viscosity. The osmolality was controlled 
by a Fiske micro-osmometer (model 210, Fiske Associates, Nor-
wood, USA). Ellman's assay served to estimate thiol concentrations 
using the procedure described in the SI (SI 2).57,58  
Formation of 1-comMS and 2-comMS. Fresh polymer solutions 
containing Na-alg-PEG or a mixture of Na-alg and Na-alg-cys-900 
were prepared as detailed in the SI (SI 3, Table S2; SI 4 Tables S3 
and S4). Unless noted otherwise, MOPS (10 mM, pH=7.4) was 
used as medium. 1-comMS and 2-comMS were produced employ-
ing a coaxial air-flow droplet generator (Encapsulator B-395 Pro, 
Büchi Labortechnik AG, Flawil, Switzerland). The polymer solu-
tion, with or without cells, was extruded into the tenfold volume of 
the gelation bath containing CaCl2 ∙ 2H2O (100 mM) in MOPS. 
The MS were collected by filtration, washed twice with CaCl2 stock 
solution, and finally stored in this solution at 4 °C, or in cell culture 
medium in case of cell microencapsulation. 
Physical Characterization of 1-comMS and 2-comMS. Simulta-
neous formation of ionic and covalent crosslinks was qualitatively 
analyzed by treatment with sodium citrate (100 mM) or TCEP 
(0.5 M). The size (swelling or shrinking) of the MS in different 
media, at RT and 37 °C, was assessed on 30 MS randomly taken at 
defined time points. The average diameter was measured on an 
Olympus AX70 microscope equipped with an Olympus DP70 col-
or digital camera. The water uptake was determined gravimetrically 
comparing the mass of the swollen and freeze-dried MS as reported 
previously.53 The mechanical resistance to 90% compression of the 
initial MS diameter was analyzed using a texture analyzer (TA-
XT2i, software Texture Exponent 32, Stable Micro Systems, Go-
dalming, UK) equipped with a force transducer (1 mN resolution). 
A single MS was placed below the probe, for which a constant 
speed was set as 0.5 mm s-1. Thirty MS of each batch were included 
in the analysis. The permeability of the MS was studied by measur-
ing the ingress diffusion of FITC-dextran standards (40, 70, 150 kg 
 mol-1). Prior to the measurement, the MS were equilibrated in the 
gelation bath. 700 mg of MS, collected by filtration and gently dried 
on paper, were incubated in 1 mL of FITC-dextran solution (1 mg 
mL-1 in 100 mM CaCl2 solution). 40 μL of the supernatant were 
withdrawn after 1 min (t = 0) and at defined time intervals, and 
diluted in 600 μL of the gelation bath. Fluorescence spectroscopy 
(Multiplate Reader Safire- II Tecan, Maennedorf, Switzerland) was 
used to monitor the FITC-dextran concentration.  
Microencapsulation of EDX Cells. Primary human foreskin fi-
broblasts (herein designated as EDX cells, provided by DFB Bio-
science) were cultured and prepared for the microencapsulation as 
described previously.54 Microencapsulation was performed using a 
3.5 wt % solution of Na-alg-PEG-13 and the Na-alg-cys-900/Na-alg 
solution described in the SI (Table S4). Encapsulated EDX cells 
were cultured in Iscove’s modified Dulbecco’s Medium (IMDM) 
(Cambrex, Verviers, Belgium) supplemented with 10% fetal calf 
serum (Invitrogen, Basel, Switzerland), 100 IU mL-1 penicillin, 100 
mg mL-1 streptomycin (Gibco-Invitrogen), dithiothreitol (Sigma, 
St-Louis, USA) and 10 ng mL-1 Platelet Derived Growth Factor BB 
(PDGF-BB, Peprotech EC Ltd, London, UK). The medium was 
changed every 3 days until one month of culture. 
To assess viability and mortality, encapsulated cells were stained 
with fluorescein diacetate (FDA) and propidium iodide (PI) for 2 
min and images were taken by fluorescence microscopy.54 MS are 
permeable to FDA and PI, so that these stains can be used for as-
sessment of encapsulated cells. The data was quantified using Im-
ageJ software (http://rsbweb.nih.gov/ij) 
Statistics. Unless otherwise noted, the results were expressed as 
the mean ± standard deviation (SD).  
 
RESULTS AND DISCUSSION  
Functionalization of Na-alg with PEG. Two principal synthesis 
pathways were followed for the functionalization of Na-alg hydrox-
yl groups with heterobifunctional PEG. Both routes functionaliza-
tion of Na-alg by oxidation of the hydroxyl groups59 and functional-
ization of Na-alg by esterification derivatization allowed for suc-
cessful chemical modification of Na-alg. Nevertheless, only the 
functionalization according to Scheme 1 yielded a product, which 
was usable to form stable MS. The synthesis steps of the other 
pathway are presented in the SI (Scheme S1). 60,61 
The synthesis presented in Scheme 1 started with the conversion of 
Na-alg (1) into TBA-alg (2) with the intention to increase the sol-
ubility in organic solvents, thereby allowing the use of several or-
ganic media for a wider variety of functionalization reactions.62,63 
Spectroscopic analyses confirmed the TBA-alg structure (SI 5, 
Figure S1). In particular, the 1H-NMR spectrum of compound (2) 
revealed peaks at 3.12, 1.57, 1.28, and 0.86 ppm corresponding to 
CH2 and CH3 moieties of the butyl residues. Insertion of new car-
boxylate groups was achieved via the reaction of TBA-alg with suc-
cinic anhydride in the presence of pyridine in DMSO.62-64 This 
approach allows preferential functionalization of the mannuronic 
acid residues of the alginate backbone, as these are more soluble in 
DMSO, thereby keeping the less sterically hindered  guluronic acid 
residues available for ionic crosslinking. The derivatization oc-
curred favorably on the hydroxyl group in C3 position of the man-
nuronic residue and on the hydroxyl group in C2 position of the 
guluronic residue because the other hydroxyl groups are involved in 
a 1,3 diaxial interaction.62,63 NH2-PEG-SH was conjugated to the 
intermediate (3) through a coupling reaction to afford compound 
(4) which displays terminal thiol moieties for covalent crosslinking. 
The expected chemical structures were confirmed by spectroscopy 
(SI 5, Figures S2 and S3). The 1H-NMR spectrum of compound 
(4) displayed peaks at 3.57 and 1.03 ppm corresponding to PEG 
CH2 groups and SH moieties, respectively. In the 13C-NMR spec-
tra, peaks at 176.3, 174.0 and 172.7 ppm give evidence for the pres-
ence of ester, carboxylate and amide C=O moieties. 
 
Scheme 1. Synthesis of Na-alg-PEG (4): Functionalization of 
Na-alg by esterification derivatization. 
 
 
Screening different reaction and purification conditions (SI 1, Ta-
ble S1) served to identify optimal protocols to yield Na-alg-PEG 
able to form stable, mechanically resistant 1-comMS. To identify 
the optimal conditions for the esterification reaction, different 
amounts of succinic anhydride/pyridine reagents were added and 
the reaction time was set at 1 or 2 h. As already demonstrated by 
Pawar et al.62 for the acetylation of the alginate backbone, the reac-
tion time strongly affects the molar mass reduction of TBA-alg, 
indicated by the viscosity of the solutions (Table 1). Either a low 
amount of succinic anhydride/pyridine (0.5 equiv./0.43 equiv.) for 
2 h, or 2 equiv./1.7 equiv. of succinic anhydride/pyridine for 1 h, 
yielded intermediate products (3) allowing the formation of stable 
1-comMS upon coupling of NH2-PEG-SH. 
The conjugation of the PEG derivative to intermediate (3) re-
quired a low amount of NH2-PEG-SH (0.2 equiv.) in combination 
with EDC (2.2 equiv.) as coupling reagent to yield the desired 
grafted Na-alg-PEG. Coupling reagents allowing the reaction to 
occur in water were preferred. A mixture of NHS/EDC was also 
used, and resulted in completion of the reaction after 30 min (en-
tries 1-4 in Table S1).65 However, to hydrolyze the residual NHS-
activated carboxylic acid groups at the end of the reaction, NaOH 
was required which caused substantial degradation of the alginate 
backbone chain. As result of the optimization, only EDC was se-
lected as coupling reagent and the reaction time was fixed to 2 h.65,66 
Unreacted activated carboxylic acid was hydrolyzed during the 
 dialysis step by adding a solution of MES, slightly acidic, accelerat-
ing the hydrolysis reaction.67 
 
Table 1. Optimized Conditions to Produce Na-alg-PEG 
reagent/parameter product 
 Na-alg-PEG-11 Na-alg-PEG-13 
esterification 
succinic anhydride 
(equiv.) 
0.5 2.0 
pyridine (equiv.) 0.43 1.7 
time (h) 2 1 
temperature (°C) 40 40 
viscositya (mPa s) 384 541 
grafting 
NH2-PEG-SH (equiv.) 0.2 0.2 
EDC (equiv.) 2.2 2.2 
time (h) 2 2 
temperature (°C) RT RT 
degree of graftingb (%) 5 5 
a viscosity of the solution containing 2.5 wt % intermediate (5). bby 
1H-NMR 
The addition of an optimized amount of TCEP, as specified in the 
experimental section, prevented disulfide bond formation during 
the purification by dialysis. The optimization of this amount en-
sured that no excess of TCEP was left in the final product. MES 
served as buffer to facilitate the hydrolysis of the activated carbox-
ylic acid. Neutralization was performed at day 2 of the dialysis. 
EDC liberates hydrochloric acid during the coupling reaction, and 
consequently TBA-alg was partially converted into alginic acid. 
Adjusting the pH between 7 and 8 (NaOH) led to regeneration of 
the sodium salt. Two reaction conditions out of 15 (SI 1, Table S1, 
entries 11 and 13) were finally identified to yield PEG-
functionalized Na-alg able to form the expected 1-comMS upon 
extrusion of the polymer solution into the gelation bath containing 
only CaCl2 as crosslinker.  
Functionalization of Na-alg with Cysteamine. Na-alg-cys (5) 
was prepared as shown in Scheme 2, with Kelton HV as the starting 
Na-alg.  
 
Scheme 2. Synthesis of Na-alg-cys (5): Functionalization of 
Na-alg with cystamine dihydrochloride via amide bonding 
followed by disulfide bond reduction. 
 
 
The efficiency of the graft reaction, that takes place at the carboxyl 
groups, was confirmed by 1H-NMR and 13C-NMR (SI 5, Figure 
S4). The 1H-NMR spectrum showed two peaks (2.62 and 3.1 ppm) 
corresponding to cysteamine. Grafting evidence was provided by 
13C-NMR. A single signal of carboxylate groups was detected for 
the native Na-alg while for Na-alg-cys a new peak appeared at 160.6 
ppm downfield by approx. 15 ppm in comparison with the corre-
sponding alginate carboxyl. This new peak is attributed to the car-
bonyl of the amide group. Together, these results suggest that the 
cysteamine moieties that remained after dialysis are grafted onto 
the Na-alg backbone. The degree of grafting, which refers to the 
percent of modified carboxylate groups on Na-alg, was quantified 
by both 1H-NMR and Ellman's assay (SI 2).57 Adding different 
amounts of EDC to the reaction mixture (500, 700, 900 mg) yields 
products with different degrees of grafting (Figure 1). The 1H-
NMR analysis always yielded about 5% higher values for the degree 
of grafting than Ellman's assay. This deviation exceeds the error of 
the individual methods, but seems to be a systematic error. To 
avoid discrepancies related to the degree of grafting, exclusively Na-
alg-cys-900 was subsequently used for all experiments in this study.  
 
Figure 1. Degree of grafting as a function of the EDC amount added to 
the reaction, comparison of 1H-NMR and Ellman’s assay.57 The error 
bars refer to the SD of n = 3 independent reactions. 
 
The functionalization was accompanied by chain degradation. 
Compared to the intrinsic viscosity of the starting Na-alg Kelton 
HV (813 mL g-1 in 0.1 M NaCl, T = 25°C), the intrinsic viscosity of 
the graft product Na-alg-cys-900 (216 mL g-1) was significantly 
lower.  
Hydrogel Formation by Grafted Disulfide Bonds.  Spontaneous 
hydrogel formation was observed upon exposure of Na-alg-PEG or 
Na-alg-cys solutions to air. The degree of grafting, the polymer 
concentration and the temperature govern the gelation rate. The 
photographs of Figure 2 confirm the disulfide bond formation for 
Na-alg-cys.68 
 
A  B  C  
Figure 2. Confirmation of disulfide bond formation. (A) Clear solu-
tions of Na-alg-cys-900 (2 wt % in MOPS); (B) chemical hydrogel via 
spontaneous disulfide bond formation at RT; (C) dissolution of the 
hydrogel upon adding the reducing agent TCEP to vial 1.  
 
In this figure, the complete dissolution of Na-alg-cys-900 (20 mg) 
in MOPS (1 mL) was achieved in vial 1 and 2 after a few minutes 
shaking (Figure 2A). Spontaneous hydrogel formation took place 
within 36 h storage at RT without adding any crosslinker to the 
solutions (Figure 2B). Adding TCEP (200 μL, 0.5 M in water) to 
vial 1 and only 200 μL pure water to vial 2 confirmed that the gel 
formation is driven by disulfide bond formation. As visible in Fig-
ure 2C, the hydrogel in vial 1 was completely dissolved due to the 
reduction of disulfide bonds by TCEP, while the hydrogel in vial 2 
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 did only absorb some water, which led to slight increase of the hy-
drogel volume (swelling). A similar photo as in Figure 2C was tak-
en after 24 h, confirming that TCEP irreversibly reduces disulfide 
bonds.69  
The influence of the temperature on the disulfide bond formation 
rate is shown in Figure 3 for 2 wt % of Na-alg-cys-900 in MOPS. At 
37 °C, more than 50% of the initial thiol reacted after 2 days, while 
only a limited amount did so at 4 °C. After an almost linear de-
crease of the thiol concentration during the first two days, the reac-
tion leveled off until day 6 probably due to reduced mobility of the 
polymer chains in the hydrogel. The viscosity of the solution 
strongly increased upon gelation by disulfide bond formation. This 
viscosity increase reduced the chain mobility and consequently 
hindered the thiol groups to approach and further react. The low 
conversion rate at 4 °C is advantageous for the solution preparation 
and storage of the solution prior to cell microencapsulation 
 
 
Figure 3. Gelation kinetics of Na-alg-cys-900 (2 wt % in MOPS) at 
different temperatures. The decrease of the absorbance at 412 nm 
refers to the thiol consumption.57 
 
Combining the information presented in Figures 2 and 3, it is 
tempting to suggest that for a high degree of grafting, such as for 
Na-alg-cys-900, even a relatively low conversion of thiol groups 
after about 36 h at RT is sufficient to form a stable covalently cross-
linked hydrogel.68 
For another product, which was obtained by conjugating cystein 
hydrochloride to alginic acid, no spontaneous disulfid bond for-
mation was reported. Instead, both the new thiol and carboxyl 
functionality added to the alginate backbone by this synthesis 
pathway participated in complexation with divalent zinc cations.70 
Microsphere Formation. The slowly occurring covalent disulfide 
bond formation impairs the production of spherical hydrogels 
when this is done using simple extrusion technology. Neither of the 
two modified Na-alg types yielded stable MS without the support 
of ionic crosslinking. Both 1-comMS and 2-comMS were fabricated 
by extruding either Na-alg-PEG solutions alone or mixtures of Na-
alg-cys/Na-alg solutions into the gelation bath containing CaCl2 as 
ionic crosslinker. Simultaneously occurring ionic and covalent 
crosslinking was confirmed by exposing the MS either to sodium 
citrate, which interferes the ionic links, or to TCEP, which chemi-
cally reduces the covalent bonds.69 This is demonstrated in Figure 4 
for 2-comMS. While Ca-alg MS prepared from pure Na-alg solu-
tions dissolved upon exposure to sodium citrate, the 2-comMS 
remained stable and maintained their spherical shape and size.  
Different from Na-alg-PEG, Na-alg-cys alone did not form cova-
lently reinforced 1-comMS at any degree of grafting. At very low 
degree of grafting, approx. 5% according to Ellman's assay, MS were 
formed but dissolved upon exposure to sodium citrate due to an 
insufficient number of covalent crosslinks. Increasing the degree of 
grafting above this value, Na-alg-cys droplets did not yield stable 
MS in the gelation bath, but either dissolved or formed irregularly 
shaped gels. This can be attributed to too slowly occurring ionic 
crosslinking probably due to the lack of sufficient residual carbox-
ylic groups. Another factor causing badly shaped gels is chain deg-
radation that occurred during the synthesis. Indeed, because of the 
relatively low viscosity of the Na-alg-cys-900 solutions, the droplets 
entered the gelation bath not at all, or only in deformed shape. 
Mixing Na-alg-cys with native Na-alg overcame this problem. The 
presence of Na-alg ensured fast gelation while maintaining the 
spherical shape of the droplet and Na-alg-cys reinforced the initially 
formed hydrogel by forming an interpenetrating covalently cross-
linked gel structure. 
    
 
Figure 4. Stability of MS upon exposure to sodium citrate. Upper row 
(left to right): 3 wt % Na-alg alone; 2 wt % Na-alg + 1 wt % Na-alg-cys-
900; 1 wt % Na-alg + 2 wt % Na-alg-cys-900; lower row: same batches 
after treatment with sodium citrate (100 mM) for 24 h; bars 200 µm. 
 
The length of the grafted side chain presents an important differ-
ence between Na-alg-PEG and Na-alg-cys. While the short cys-
teamine graft (Scheme 2) certainly favors sterically the ionic cross-
linking, it limits the probability of covalent links. The opposite 
situation applies for the Na-alg-PEG grafted in this study with a 
PEG derivative of 2000 g mol-1, corresponding to a degree of 
polymerization of about 45 (Scheme 1). The flexibility of the long-
er side chain will certainly favor covalent links. 
Microsphere Characterization. The major aim of this study was 
to demonstrate to which extent the functionalization of Na-alg 
could overcome some known shortcomings of the physical proper-
ties of Ca-alg MS, which are in particular their limited mechanical 
resistance, insufficient durability, and high permeability.5,7,8,14-17 To 
this end, the MS were evaluated with respect to swelling behavior, 
size and chemical stability in different media, water uptake, me-
chanical resistance to compression, and permeability. The compar-
ison of 1-comMS and 2-comMS was not the primary interest.  
However, discussing improvements one has to be aware of the 
extreme variability of the natural compound Na-alg including the 
alternation of the guluronic and mannuronic units along the poly-
mer backbone, the molar mass and the molar mass distribution. All 
these macromolecular peculiarities, and also the Na-alg concentra-
tion and the gelation technology, affect the hydrogel properties of 
the Ca-alg MS. These topics have been widely published and re-
viewed in the literature.10,14,71,72 
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 Swelling/shrinking. Table 2 and Figure 5 show the swell-
ing/shrinking behavior of 1-comMS when transferred from the 
gelation bath into water, at RT and 37 °C. The ionic strength in 
water is lower than in the gelation bath (CaCl2, MOPS). As a con-
sequence, an extension of the ionic polymer network is expected 
when MS are put in water. The data in Table 2 reflect this extension 
quantitatively and show the influence of the polymer concentra-
tion. A higher Na-alg-PEG concentration yielded denser croslinked 
hydrogels due to the potentially higher amount of ionic and cova-
lent crosslinks per volume unit. 
 
Table 2. Diameter of 1-comMS Prepared from Two Different 
Concentrations of Na-alg-PEG-13 after 3 Days Storage in the 
Gelation Bath (d3) and Subsequently Incubated for 48 h in 
Water at RT (d48, water) 
ca 
(wt %) 
d3 
(µm) 
d48, water 
(µm) 
Δd/ΔV 
(%) 
2.5 557 ± 66 582 ± 75 +4.4 / +14 
5.0 627 ± 70 639 ± 93 +2.0 / +6.0 
aConcentration of the polymer in MOPS (10 mM, pH=7.4) 
 
Storage at 37 °C for one month confirmed the hydrogel stability 
over this period (Figure 5). To ensure complete covalent crosslink-
ing, the MS were first kept for 6 days in the gelation bath before 
transferring them in water. After initial expansion in water, no fur-
ther significant size variation was observed over 4 weeks at 37 °C. In 
view of future biomedical application, the MS integrity and stability 
was evaluated in several culture media and was confirmed not only 
for MOPS but also for DMEM and RPMI over a period of two 
months at 37 °C. 
 
 
Figure 5. Influence of the medium and temperature on the 1-comMS 
size (3.5 wt %) at RT in the gelation bath and at 37 °C in water (box 
plot, n=30). 
 
Four formulations (Table 3) have been used to estimate the physi-
cal properties of the 2-comMS. Pure Ca-alg MS were prepared at 
the same total concentrations indicated in Table 3 and used for 
comparison.  
Upon exposure of the 2-comMS of formulations 1-4 and appropri-
ate Ca-alg MS to aqueous sodium citrate solutions (5 mM), differ-
ences in terms of water uptake capacity related to 1 g polymer be-
came obvious (Figure 6A). Such a low citrate concentration only 
slightly weakens the ionic network but ensures the integrity of the 
MS. Comparing the total initial polymer concentrations in Table 3 
with the polymer concentrations calculated from the data shown in 
Figure 6A, a dilution/volume swelling by a factor of 2.0-2.2 was 
evident for Ca-alg MS while for the 2-comMS shrinking by a factor 
of 0.8-0.7 was observed. However, it cannot be excluded that the 
droplet shrinking took already place during the covalent crosslink-
ing, before the MS were transferred into the citrate solution.  Tak-
ing formulation 3 as example, the initial polymer concentration of 
2.5 wt % reduced to 1.16 wt % in the Ca-alg MS but increased to 
3.51 wt % in the 2-comMS (Figure 6B). This clearly demonstrates 
the reinforcement of the hydrogel by Na-alg-cys. At this low sodi-
um citrate concentration, the Ca-alg MS remained intact but 
strongly swelled. Assuming a similar weakening of the ionic net-
work in the 2-comMS suggests that the network properties are 
governed by the covalent crosslinks. Even for formulation 1, where 
only 0.5 wt % of Na-alg-cys was present, the concentration in-
creased from 1.5 wt % to 1.9 wt %, but decreased to from 1.5 wt % 
to 0.7 wt % for the pure Ca-alg (Figure 6B).   
 
Table 3. Composition of 2-comMS Preparations in MOPS (10 
mM, pH=7.4) 
formulation total 
(wt %) 
Na-alg-cys-900 
(wt %) 
Na-alga 
(wt %) 
1 1.5 0.5 1.0 
2 2.0 1.0 1.0 
3 2.5 1.5 1.0 
4 3.0 2.0 1.0 
a Kelton LV 
   
Figure 6. Influence of the MS composition on water uptake and final 
polymer concentration in the MS. (A) 2-comMS formulations and MS 
prepared from pure Na-alg, 48 h exposure to 5 mM sodium citrate at 
RT (average ± SD, n=3); (B) polymer concentration after 48 h, calcu-
lated from average values in (A).  
 
Mechanical properties. The measurement of the mechanical re-
sistance to uniaxial compression three days after the formation of 1-
comMS ensured the completion of disulfide bond formations. Typ-
ical compression curves are presented in the SI (SI 6, Figure S5).  
Minimal mechanical resistance was monitored when compressing 
the MS until 40-50% of their initial diameter, followed by a slight 
increase until around 70%, before becoming exponential until 90% 
compression. Figure 7A presents the mechanical resistance at 90% 
compression of 1-comMS prepared in the concentration limits 2.5 
to 5.0 wt % where MS can be formed. The resistance increased with 
the Na-alg-PEG concentration but remained in the range of pure 
Ca-alg MS. Nevertheless, improvement of the mechanical proper-
ties was achieved in terms of shape recovery upon repeated com-
pression to 90% of the MS diameter (Figure 7C). The known het-
erogeneous gelation of Na-alg, in particular at higher Na-alg con-
centration, is one possible reason for this phenomenon.55 With 
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 increasing Na-alg concentration, a maximum of recovery perfor-
mance was passed: MS of 2.5 wt % Na-alg performed better than 
MS of 4 wt % Na-alg. The improvement for the 1-comMS is at-
tributed to covalent crosslinking. Figures 7B and 7D present the 
comparison of the mechanical properties for 2-comMS and Ca-alg. 
The better mechanical resistance to one and multiple compressions 
is evident, and ascribed to the covalent crosslinking of the cysteam-
ine grafted Na-alg inside the Ca-alg matrix. Moreover it is likely 
that the Na-alg-cys also participates in the ionic crosslinking by 
calcium ions.  
 
 
Figure 7. Mechanical resistance to uniaxial compression to 90 % of the 
initial MS diameter. (A) increase of the mechanical resistance of 1-
comMS with the Na-alg-PEG-13 concentration; (B) increase of the 
resistance as a function of the composition of 2-comMS and Ca-alg 
MS; (C) resistance to 10 successive compressions of 1-comMS (3.5 wt 
%) and Ca-alg (2.5 and 4 wt %); (D) resistance to 10 successive com-
pressions of 2-comMS (formulation 4 in Table 3) and Ca-alg MS.  
 
Permeability. 150 kg mol-1 is generally considered a threshold above 
which MS intended for cell microencapsulation and subsequent 
transplantation should exclude any compound. This threshold can 
hardly be achieved by Ca-alg. The results of the permeability as-
sessment by ingress diffusion of FITC-Dextran standards are 
shown in Figure 8 and in SI 7 Figure S6. While FITC-Dextran of 40 
kg mol-1 permeated all MS types formed at any composition and 
polymer concentration, MS produced using Na-alg-PEG-13 at 5 wt 
% completely exclude FITC-Dextran 70 kg mol-1 (Figure 8B). Con-
sequently, the MWCO can be expected between 40 and 70 kg mol-
1. Such a dense polymer network could be achieved neither for Na-
alg-PEG-11 nor for the 2-comMS or Ca-alg, even not at the highest 
concentrations tested in terms of mechanical stability. A minimum 
of 2 wt % Na-alg-cys-900 is needed in the 2-comMS formulation to 
ensure a MWCO of 150 kg mol-1 (SI 7, Figure S6). Worth mention-
ing, the permeability is not a static value but depends strongly on 
the environment of the MS.71 
 
             
Figure 8. Influence of the Na-alg-PEG-13 concentration on the per-
meability of 1-comMS, assessed by ingress diffusion of FITC-Dextran, 
(A) 40 kg mol-1, (B) 70 kg mol-1, (average ± SD, n=3). 
 
Cell Microencapsulation. The feasibility of cell microencapsula-
tion in 1-comMS and 2-comMS (diameter 500-600 µm) was con-
firmed using primary human foreskin fibroblasts as model cells.54 
The cells were homogeneously distributed within both MS types 
(Figures 9A, 9D).   
 
A             
C   
D  
Figure 9. Microencapsulation of EDX cells. (A) at day 0 in 1-comMS, 
Na-alg-PEG-13 3.5 wt %; (B) viability of microencapsulated EDX cells; 
(C) at day 30, from left to right: light microscopy, viability staining of 
the same object with FDA (green: living cells), PI staining (red: dead 
cells); (D) at day 0 in 2-comMS, 2 wt % Na-alg-cys + 1.5 wt % Na-alg. 
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 Furthermore, no free EDX cells were identified in the gelation bath 
indicating no out-diffusion of the cells from the polymer solution 
drops during the gelation process. Thus, the fact that covalent 
crosslinking immediately after the extrusion into the gelation bath 
is incomplete seemed not to be unfavorable. The cell viability as-
sessed by FDA/PI staining, revealed good survival immediately 
after the microencapsulation process and during a subsequent 4-
week culture (Figures 9B, 9C). No significant decrease in cell via-
bility compared to free cells was observed suggesting that the new 
PEG-modified and cys-modified Na-alg are cytocompatible. 
 
CONCLUSIONS 
Two synthesis principles were presented which add tailor-made 
thiol chemical self-crosslinking functionality to the biopolymer 
sodium alginate either as thiol end groups of grafted heterobifunc-
tional PEG or as cysteamine. It was proven that ionic gelation with 
calcium ions and covalent self-crosslinking of the thiol groups oc-
curred simultaneously and lead to the targeted improvement of the 
mechanical properties and permeability compared to pure Ca-alg 
MS. The degree of grafting, polymer concentration, and chemical 
composition were identified as the critical parameters to vary the 
MS properties and adapt these to future cell microencapsulation 
applications. Preliminary in vitro studies demonstrated cytocom-
patibility of the materials and process, but this has to be confirmed 
for other cell types and specific applications. 
In particular favorable are the absence of both polycations and 
chemical crosslinkers as well as the mild and simple one-step MS 
formation process, which can take place in cell culture media. The 
availability of such novel hydrogel materials that can be manufac-
tured as microspheres with adaptable properties suitable for cell 
microencapsulation is considered crucial for accelerating the pro-
gress and clinical translation of innovative cell therapies.  
Moreover, from the gelation mechanisms of the formulations con-
taining the novel synthesized alginate derivatives, suitability for 
other technologies including microfluidics can be concluded. Final-
ly, the selected synthesis pathways and functional end groups add-
ed to the alginate backbone offer the possibility to conjugate bioac-
tive compounds for controlled and localized release in specific ap-
plications. Overall, the two novel MS types extend the materials 
basis for cell microencapsulation. 
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